Fostering Prosocial Preventive Behaviours Through Awe

February 24, 2026 updated by: Qiuyan Liao, The University of Hong Kong

Fostering Prosocial Behaviours Against Infectious Diseases Through Awe: A Randomized Controlled Trial

The goal of this randomized control trial is to investigate the impact pf awe on prosocial preventive behaviours against infectious diseases among adults from Hong Kong, Singapore, and ten major cities in Mainland China (Beijing, Shanghai, Guangzhou, Shenzhen, Hangzhou, Chongqing, Chengdu, Wuhan, Xi'an, Nanjing). The main questions it aims to answer are:

  • Does experiencing awe increase adults' intentions to engage in prosocial preventive behaviours against infectious diseases, including vaccination, mask wearing, and social distancing?
  • Does the impact vary across three research sites?

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Recruiting

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

This study will be conducted as a nested sub-study within a main longitudinal study implemented online. The baseline assessment of the longitudinal study was conducted between October and November 2025. Participants who agreed to be recontacted will be invited to join the randomized controlled trial (RCT) approximately four months after the baseline assessment, in February-March 2026. At that time, participants will be randomized in a 1:1 ratio into either the intervention or control group.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Estimated)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
456

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact

The name and contact information for the person who can answer enrollment questions for a clinical study. Each location where the study is being conducted may also have a specific contact, who may be better able to answer those questions.

Study Locations

  • Hong Kong
      • Hong Kong, Hong Kong
        • Recruiting
        • University of Hong Kong School of Public Health
        • Contact:
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Adults (age ≥18 years) who live in
  • Hong Kong, Singapore, and ten major cities in Mainland China (Beijing, Shanghai, Guangzhou, Shenzhen, Hangzhou, Chongqing, Chengdu, Wuhan, Xi'an, Nanjing) over the past one year
  • Able to read and understand written Chinese or English
  • Have access to the internet through computers, mobile phones, or tablets

Exclusion Criteria:

  • Individuals with cognitive or linguistic difficulties that would prevent them from completing an online survey will be excluded.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Experimental: Awe intervention group
The intervention is a three-step mini game named Hidden Picture Puzzle designed to induce the feeling of awe. In the game, participants will first see a picture of nature covered by six opaque blocks. They will be asked to guess the content of the picture. After making their choice, participants will be instructed to click the six blocks to gradually uncover the picture. Once all six blocks are removed, the full image will be revealed. In the final step, participants will be instructed to imagine themselves in the scene and describe their feelings by selecting the word from a provided list. To ensure that participants will have sufficient time to complete the imagination tasks, they will be required to pause for at least 15s before proceeding to indicate their immediate feeling. Each participant will complete four rounds of this mini game, each with a different picture.
Behavioral: Awe intervention
The intervention is a three-step mini game named Hidden Picture Puzzle designed to induce the feeling of awe. In the game, participants will first see a picture of nature covered by six opaque blocks. They will be asked to guess the content of the picture. After making their choice, participants will be instructed to click the six blocks to gradually uncover the picture. Once all six blocks are removed, the full image will be revealed. In the final step, participants will be instructed to imagine themselves in the scene and describe their feelings by selecting the word from a provided list. To ensure that participants will have sufficient time to complete the imagination tasks, they will be required to pause for at least 15s before proceeding to indicate their immediate feeling. Each participant will complete four rounds of this mini game, each with a different picture.
Placebo Comparator: Neutral imagination control group
For the control group, the mini game Hidden Picture Puzzle will also follow a three-step format, identical in structure to the intervention condition. However, the images provided will depict everyday objects (e.g., a sofa or a bottle) rather than nature scenes. Similarly, when participants are asked to guess the content of the picture. After the participants finish uncovering the pictures, they will be asked to imagine their interaction with these daily objects and describe the features of the objects by selecting a word from a provided list. As in the intervention group, participants in the control group will complete four rounds of the mini game, each with a different image.
Behavioral: Neutral imagination
For the control group, the mini game Hidden Picture Puzzle will also follow a three-step format, identical in structure to the intervention condition. However, the images provided will depict everyday objects (e.g., a bottle) rather than nature scenes. Similarly, when participants are asked to guess the content of the picture. After the participants finish uncovering the pictures, they will be asked to imagine their interaction with these daily objects and describe the features of the objects by selecting a word from a provided list. As in the intervention group, participants in the control group will complete four rounds of the mini game, each with a different image.

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Intentions to participate in future preventive behaviours
Time Frame: Immediately after they complete the game with manipulation
Participants will be asked about their intentions to participate in future vaccination, mask wearing, and social distancing during next winter influenza season using a 7-point Likert scale (1=Never, 7=Certain).
Immediately after they complete the game with manipulation
Behavioural choices in the pandemic vignettes
Time Frame: Immediately after they complete the game with manipulation
Based on a hypothetical infectious disease pandemic, six vignettes will be shown to the participants, comprising three on vaccination and three on social distancing. Each vignette illustrates a trade-off between personal cost and social benefit in engaging in these prosocial behaviours. Participants will be asked to report how likely will they are to engage in the prosocial preventive behaviours using a 7-point Likert scale (1=Never, 7=Certain).
Immediately after they complete the game with manipulation

Secondary Outcome Measures

Secondary Outcome Measures

In a clinical study's protocol, a planned outcome measure that is not as important as the primary outcome measure for evaluating the effect of an intervention but is still of interest. Most clinical studies have more than one secondary outcome measure.
Outcome Measure
Measure Description
Time Frame
Intentions to engage in social activities
Time Frame: Immediately after they complete the game with manipulation
Participants will also be asked their intentions to engage in social activities using a 5-point Likert scale (1=Very unwilling, 5=Very willing).
Immediately after they complete the game with manipulation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
The University of Hong Kong

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
October 27, 2025

Primary Completion (Estimated)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
March 31, 2026

Study Completion (Estimated)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
October 31, 2026

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
February 5, 2026

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
February 5, 2026

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
February 12, 2026

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
February 27, 2026

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
February 24, 2026

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
February 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • Socialconhealth2025

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings